EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Stress and CKD Among African Americans

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Behavioral: Racialized Stressful Event Recall
Behavioral: Non-Racialized Stressful Event Recall

First Posted Date: 2018-01-02

Last Posted Date: 2020-05-12

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT03387319

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

CBT for African Americans With Cognitive Impairment

Not Applicable

Completed

Conditions: Alzheimer Disease

Interventions: Behavioral: Group-based Cognitive Behavioral Therapy (CBT)
Behavioral: Phone-based Cognitive Behavioral Therapy (CBT)

First Posted Date: 2017-12-27

Last Posted Date: 2020-04-29

Lead Sponsor: Emory University

Target Recruit Count: 31

Registration Number: NCT03384069

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States

iEAT 2.0 Open Trial

Not Applicable

Completed

Conditions: Gastrointestinal Disorders

Interventions: Behavioral: iEAT Program

First Posted Date: 2017-12-26

Last Posted Date: 2019-06-21

Lead Sponsor: Emory University

Target Recruit Count: 15

Registration Number: NCT03383029

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Exercise and RP (AVAMC and Emory)

Not Applicable

Completed

Conditions: Retinitis Pigmentosa

Interventions: Other: Spin exercise

First Posted Date: 2017-12-21

Last Posted Date: 2018-12-26

Lead Sponsor: Emory University

Target Recruit Count: 4

Registration Number: NCT03381235

Locations: 🇺🇸
Emory Clinic, Atlanta VA Medical Center, Atlanta, Georgia, United States

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Phase 1

Completed

Conditions: Resectable Pancreatic Carcinoma
Pancreatic Adenocarcinoma
Stage II Pancreatic Cancer
Stage IV Colorectal Cancer
Colon Carcinoma Metastatic in the Liver
Colorectal Adenocarcinoma
Stage IIB Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IVB Colorectal Cancer
Stage I Pancreatic Cancer

Interventions: Procedure: Surgery
Biological: Anti-SEMA4D Monoclonal Antibody VX15/2503
Biological: Nivolumab
Biological: Ipilimumab

First Posted Date: 2017-12-14

Last Posted Date: 2024-03-20

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT03373188

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

and more 1 locations

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

Phase 1

Active, not recruiting

Conditions: Colorectal Adenocarcinoma
Stage IVB Colorectal Cancer
Gastric Adenocarcinoma
Stage III Colorectal Cancer
Metastatic Pancreatic Adenocarcinoma
Stage IVA Colorectal Cancer
Non-Resectable Cholangiocarcinoma
Stage IV Colorectal Cancer
Stage III Gastric Cancer
Stage IV Gastric Cancer

Interventions: Drug: Nanoliposomal Irinotecan
Drug: Trifluridine and Tipiracil Hydrochloride

First Posted Date: 2017-12-11

Last Posted Date: 2025-01-07

Lead Sponsor: Emory University

Target Recruit Count: 64

Registration Number: NCT03368963

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

Improving Mitral Repair for Functional Mitral Regurgitation

Not Applicable

Completed

Conditions: Cardiomyopathy
Congestive Heart Failure
Valvular Heart Disease
Heart Disease
Cardiovascular Diseases
Coronary Artery Disease
Mitral Valve Disease

Interventions: Procedure: Undersizing Mitral Annuloplasty
Procedure: Papillary Muscle Approximation

First Posted Date: 2017-12-08

Last Posted Date: 2024-01-29

Lead Sponsor: Emory University

Target Recruit Count: 34

Registration Number: NCT03366649

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory St. Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program

Suspended

Conditions: Clostridium Difficile Infection

Interventions: Other: Microbiota Enrichment Program (MEP)

First Posted Date: 2017-11-22

Last Posted Date: 2024-05-10

Lead Sponsor: Emory University

Target Recruit Count: 200

Registration Number: NCT03350711

Locations: 🇺🇸
Emory Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Clinic, Atlanta, Georgia, United States
🇺🇸
The Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

Phase 4

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Degludec
Drug: Glargine
Drug: Aspart

First Posted Date: 2017-11-08

Last Posted Date: 2022-03-31

Lead Sponsor: Emory University

Target Recruit Count: 180

Registration Number: NCT03336528

Locations: 🇺🇸
Emory University Hospital Clinical Research Network, Atlanta, Georgia, United States
🇺🇸
Grady Hospital, Atlanta, Georgia, United States
🇺🇸
Mount Sinai, New York, New York, United States

and more 1 locations

Primary Prevention of Intimate Partner Violence in India

Not Applicable

Completed

Conditions: Intimate Partner Violence

Interventions: Behavioral: Intimate Partner Violence (IPV) Prevention Intervention

First Posted Date: 2017-11-06

Last Posted Date: 2019-01-29

Lead Sponsor: Emory University

Target Recruit Count: 80

Registration Number: NCT03332134

Locations: 🇮🇳
National AIDS Research Institute, Pune, Maharashtra, India

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy